Lack of estrogenic or (anti-)androgenic effects of d-phenothrin in the uterotrophic and Hershberger assays

Toxicology

Volumn 186, Issue 3, 2003, Pages 227-239

  Yamada, Tomoya ^a   Ueda, Shinji ^a   Yoshioka, Kaoru ^a   Kawamura, Satoshi ^a   Seki, Takaki ^a   Okuno, Yasuyoshi ^a   Mikami, Nobuyoshi ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

d Phenothrin; Endocrine disruptor; Hershberger assay; Pyrethroid; Sumithrin; Uterotrophic assay

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 11 OXOTESTOSTERONE; ANDROSTANOLONE; ETHINYLESTRADIOL; METHYLTESTOSTERONE; PHENOTHRIN;

ANDROGEN BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; ASSAY; BODY WEIGHT; CASTRATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; FOOD INTAKE; IN VIVO STUDY; LEVATOR ANI MUSCLE; LIVER WEIGHT; MALE; NONHUMAN; PENIS GLANS; PRIORITY JOURNAL; PROSTATE; RAT; RELIABILITY; SCREENING TEST; SEMINAL VESICLE; TOXICITY TESTING; UTERUS WEIGHT;

GLANS;

EID: 0037461119     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00750-3     Document Type: Article

References (37)

1. Ankley G.T., Johnson R.D., Detenbeck N.E., Bradbury S.P. Development of a research strategy for assessing the ecological risk of endocrine disruptors. Rev. Toxicol. 1:1997;71-106.
2. Ashby J., Lefevre P.A. The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators. J. Appl. Toxicol. 20:2000;35-47.
3. Ashby J., Lefevre P.A. Preliminary evaluation of the major protocol variables for the Hershberger castrated male rat assay for the detection of androgens, anti-androgens and metabolic modulators. Regul. Toxicol. Pharmacol. 31:2000;92-105.
4. Brody, S.A., Winterer, J., Drum, M.A., Barnes, K., Eil, C., Loriaux, D.L., 1983. An epidemic of gynecomastia among Haitian refugees: possible exposure to an anti-androgen. In: Proceedings of the Program and Abstracts of the 65th Annual Meeting of the Endocrine Society, San Antonio, TX, p. 261.
5. Colborn T., Vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:1993;378-384.
6. Cook J.C., Kaplan A.M., Davis L.G., O'Connor J.C. Development of a tier I screening battery for detecting endocrine-active compounds (EACs). Regul. Toxicol. Pharmacol. 26:1997;60-68.
7. EDSTAC, 1998. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report.
8. Eil C., Nisula B.C. The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J. Steroid. Biochem. 35:1990;409-414.
9. Emerson K., Wilson J.D. Diseases of the Breast and of Milk Formation. 1980;1787-1790 McGraw-Hill, New York.
10. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:1997;205-212.
11. Garey J., Wolff M.S. Estrogenic and antiprogestagenic activities of pyrethroid insecticides. Biochem. Biophys. Res. Commun. 251:1998;855-859.
12. Go V., Garey J., Wolff M.S., Pogo B.G.T. Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line. Environ. Health Perspect. 107:1999;173-177.
13. Hershberger L.G., Shipley E.G., Meyer R.K. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc. Soc. Exp. Biol. Med. 83:1953;175-180.
14. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Ashby J., Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ. Health Perspect. 109:2001;785-794.
15. Kavlock R.J. Overview of endocrine disruptor research activity in the United States. Chemosphere. 39:1999;1227-1236.
16. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilsonj H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US EPA-sponsored workshop. Environ. Health Perspect. 104:1996;715-740.
17. Kelce W.R., Stone C.R., Laws S.C., Gray L.E., Kemppainen J.A., Wilson E.M. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature. 375:1995;581-585.
18. Kunimatsu T., Yamada T., Ose K., Sunami O., Kamita Y., Okuno Y., Seki T., Nakatsuka I. Lack of (anti-)androgenic or estrogenic effects of three pyrethroids (esfenvalerate, fenvalerate, and permethrin) in the Hershberger and uterotrophic assays. Regul. Toxicol. Pharmacol. 35:2002;227-237.
19. Lambright C., Ostby J., Bobseine K., Wilson V., Hotchkiss A.K., Mann P.C., Gray L.E. Jr. Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicol. Sci. 56:2000;389-399.
20. O'Connor J.C., Frame S.R., Davis L.G., Cook J.C. Detection of the environmental antiandrogen p,p′-DDE in CD and Long-Evans rats using a tier 1 screening battery and a Hershberger assay. Toxicol. Sci. 51:1999;44-53.
21. O'Connor J.C., Frame S.R., Davis L.G., Cook J.C. Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure. Toxicol. Sci. 51:1999;54-70.
22. O'Connor J.C., Davis L.G., Frame S.R., Cook J.C. Evaluation of a tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol. Sci. 54:2000;338-354.
23. Odum J., Lefevre P.A., Tittensor S., Paton D., Routledge E.J., Beresford N.A., Sumpter J.P., Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol. 25:1997;176-188.
24. OECD, 1997. Draft Detailed Review Paper: Appraisal of Test Methods for Sex-hormone Disrupting Chemicals. Environmental Health and Safety Publications, Paris.
25. Saito K., Sumida N., Ohe N., Tomigahara Y., Isobe N., Nakatsuka I., Kaneko H. Evaluation of agonistic and antagonistic effects of several chemicals, mainly pyrethroid insecticides, using three in vitro assays with human estrogen, androgen or progesterone receptor mediated mechanisms. Toxicologist. 54:2000;274. (Abstract 1100).
26. Saito K., Tomigahara Y., Ohe N., Isobe N., Nakatsuka I., Kaneko H. Lack of significant estrogenic or antiestrogenic activity of pyrethroid insecticides in three in vitro assays based on classic estrogen receptor mediated mechanisms. Toxicol. Sci. 57:2000;54-60.
27. Sattin R.W., Roisin A., Kafrissen M.E., Dugan J.B., Farer L.S. Epidemic of gynecomastia among illegal Haitian entrants. Public Health Rep. 99:1984;504-510.
28. Stevens J.T., Tobia A., Lamb J.C. IV, Tellone C., O'Neal F. FIFRA subdivision F-testing guidelines: are these test adequate to detect potential hormone activity for crop protection chemicals? J.Toxicol. Environ. Health. 50:1997;415-531.
29. Sumida K., Ooe N., Nagahori H., Saito K., Isobe N., Kaneko H., Nakatsuka I. An in vitro reporter gene assay method incorporating metabolic activation with human and rat S9 or liver microsomes. Biochem. Biophys. Res. Commun. 280:2001;85-91.
30. Sunami O., Kunimatsu T., Yamada T., Yabushita S., Sukata T., Miyata K., Kamita Y., Okuno Y., Seki T., Nakatsuka I., Matsuo M. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p′-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo. J. Toxicol. Sci. 25:2000;403-415.
31. Tinwell H., Soames A.R., Foster J.R., Ashby J. Estradiol-type activity of coumestrol in mature and immature ovariectomized rat uterotrophic assays. Environ. Health Perspect. 108:2000;631-634.
32. WHO, 1990. d-Phenothrin. In: Environmental Health Criteria96. World Health Organization, Geneva.
33. Wilson J.D., Aiman J., MacDonald P.C. The pathogenesis of gynecomastia. Adv. Intern. Med. 25:1980;1-32.
34. Yamada T., Kunimatsu T., Sako H., Yabushita S., Sukata T., Okuno Y., Matsuo M. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. Toxicol. Sci. 53:2000;289-296.
35. Yamada T., Sunami O., Kunimatsu T., Kamita Y., Okuno Y., Seki T., Nakatsuka I., Matsuo M. Dissection and weighing of accessory sex glands after formalin fixation, and a 5-day assay using young mature rats are reliable and feasible in the Hershberger assay. Toxicology. 162:2001;103-119.
36. Yamasaki K., Ashby J., Lefever P.A., Sawaki M. Comparison of reproductive tissue weights in the enhanced Hershberger assay of 17α-methyltestosterone between peripubertal and castrated rats. J. Toxicol. Pathol. 13:2000;173-178.
37. You L., Casanova M., Archibeque-Engle S., Sar M., Fan L.-Q., Heck H.d'A. Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p′-DDE. Toxicol. Sci. 45:1998;162-173.